[English] 日本語
Yorodumi- PDB-6cmr: Closed structure of active SHP2 mutant E76D bound to SHP099 inhibitor -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6cmr | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Closed structure of active SHP2 mutant E76D bound to SHP099 inhibitor | ||||||||||||
Components | Tyrosine-protein phosphatase non-receptor type 11 | ||||||||||||
Keywords | HYDROLASE/HYDROLASE Inhibitor / protein tyrosine phosphatase / src homology domain 2 / inactive state / active mutant / HYDROLASE / HYDROLASE-HYDROLASE Inhibitor complex | ||||||||||||
| Function / homology | Function and homology informationatrioventricular canal development / genitalia development / STAT5 Activation / Co-inhibition by BTLA / Netrin mediated repulsion signals / negative regulation of neutrophil activation / positive regulation of lipopolysaccharide-mediated signaling pathway / Interleukin-37 signaling / Signaling by Leptin / negative regulation of cell adhesion mediated by integrin ...atrioventricular canal development / genitalia development / STAT5 Activation / Co-inhibition by BTLA / Netrin mediated repulsion signals / negative regulation of neutrophil activation / positive regulation of lipopolysaccharide-mediated signaling pathway / Interleukin-37 signaling / Signaling by Leptin / negative regulation of cell adhesion mediated by integrin / positive regulation of ossification / MET activates PTPN11 / negative regulation of chondrocyte differentiation / face morphogenesis / Regulation of RUNX1 Expression and Activity / Signal regulatory protein family interactions / ERBB signaling pathway / Interleukin-20 family signaling / Interleukin-6 signaling / Co-inhibition by CTLA4 / PI-3K cascade:FGFR3 / STAT5 activation downstream of FLT3 ITD mutants / Platelet sensitization by LDL / negative regulation of T cell activation / PI-3K cascade:FGFR2 / peptide hormone receptor binding / PI-3K cascade:FGFR4 / MAPK3 (ERK1) activation / negative regulation of type I interferon production / PI-3K cascade:FGFR1 / regulation of type I interferon-mediated signaling pathway / MAPK1 (ERK2) activation / inner ear development / Prolactin receptor signaling / PECAM1 interactions / peptidyl-tyrosine dephosphorylation / non-membrane spanning protein tyrosine phosphatase activity / fibroblast growth factor receptor signaling pathway / Regulation of IFNA/IFNB signaling / RET signaling / positive regulation of intracellular signal transduction / Interleukin-3, Interleukin-5 and GM-CSF signaling / Co-inhibition by PD-1 / PI3K Cascade / ephrin receptor signaling pathway / positive regulation of insulin receptor signaling pathway / regulation of protein-containing complex assembly / Regulation of IFNG signaling / GAB1 signalosome / negative regulation of T cell receptor signaling pathway / negative regulation of T cell proliferation / Activated NTRK2 signals through FRS2 and FRS3 / GPVI-mediated activation cascade / T cell costimulation / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / phosphotyrosine residue binding / FRS-mediated FGFR4 signaling / phosphoprotein phosphatase activity / FRS-mediated FGFR1 signaling / protein-tyrosine-phosphatase / Tie2 Signaling / FLT3 Signaling / protein tyrosine phosphatase activity / cell adhesion molecule binding / positive regulation of interferon-beta production / Downstream signal transduction / cellular response to epidermal growth factor stimulus / protein tyrosine kinase binding / positive regulation of D-glucose import across plasma membrane / insulin receptor binding / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / Negative regulation of FGFR3 signaling / cellular response to mechanical stimulus / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Negative regulation of FGFR1 signaling / brain development / Signaling by SCF-KIT / Spry regulation of FGF signaling / receptor tyrosine kinase binding / vasodilation / epidermal growth factor receptor signaling pathway / Constitutive Signaling by Aberrant PI3K in Cancer / cytokine-mediated signaling pathway / Signaling by CSF1 (M-CSF) in myeloid cells / Interferon alpha/beta signaling / positive regulation of tumor necrosis factor production / PIP3 activates AKT signaling / heart development / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / signaling receptor complex adaptor activity / molecular adaptor activity / positive regulation of ERK1 and ERK2 cascade / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / cadherin binding / focal adhesion / protein kinase binding Similarity search - Function | ||||||||||||
| Biological species | Homo sapiens (human) | ||||||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.21 Å | ||||||||||||
Authors | Padua, R.A.P. / Sun, Y. / Marko, I. / Pitsawong, W. / Kern, D. | ||||||||||||
| Funding support | Brazil, United States, 3items
| ||||||||||||
Citation | Journal: Nat Commun / Year: 2018Title: Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2. Authors: Padua, R.A.P. / Sun, Y. / Marko, I. / Pitsawong, W. / Stiller, J.B. / Otten, R. / Kern, D. | ||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6cmr.cif.gz | 348 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6cmr.ent.gz | 237 KB | Display | PDB format |
| PDBx/mmJSON format | 6cmr.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/cm/6cmr ftp://data.pdbj.org/pub/pdb/validation_reports/cm/6cmr | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 6cmpC ![]() 6cmqC ![]() 6cmsC ![]() 4dgpS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 60990.789 Da / Num. of mol.: 1 / Mutation: E76D Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: PTPN11, PTP2C, SHPTP2 / Plasmid: pET28a / Production host: ![]() |
|---|---|
| #2: Chemical | ChemComp-5OD / |
| #3: Water | ChemComp-HOH / |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.17 Å3/Da / Density % sol: 43.19 % |
|---|---|
| Crystal grow | Temperature: 291 K / Method: vapor diffusion, sitting drop Details: 15% PEG 20,000 and 10 mM potassium hydrogen tartrate |
-Data collection
| Diffraction | Mean temperature: 100 K |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: ALS / Beamline: 8.2.2 / Wavelength: 0.99997 Å |
| Detector | Type: ADSC QUANTUM 315r / Detector: CCD / Date: Dec 14, 2017 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.99997 Å / Relative weight: 1 |
| Reflection | Resolution: 2.21→52.79 Å / Num. obs: 25969 / % possible obs: 99.92 % / Redundancy: 6.1 % / Biso Wilson estimate: 44.34 Å2 / CC1/2: 0.993 / Rmerge(I) obs: 0.1645 / Rpim(I) all: 0.07346 / Net I/σ(I): 5.85 |
| Reflection shell | Resolution: 2.21→2.289 Å / Redundancy: 6.6 % / Num. unique obs: 2566 / Rpim(I) all: 0.7128 / % possible all: 100 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 4DGP Resolution: 2.21→52.79 Å / SU ML: 0.3859 / Cross valid method: FREE R-VALUE / σ(F): 1.33 / Phase error: 29.2629 / Stereochemistry target values: GeoStd + Monomer Library
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 58.13 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.21→52.79 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Brazil,
United States, 3items
Citation













PDBj


































